Maven Securities LTD Compass Pathways PLC Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$21.81 - $48.96 $2.18 Million - $4.9 Million	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$29.03 - $38.62 $1.51 Million - $2.01 Million	-51,957 Reduced 34.19%	100,000 $2.99 Million
Q2 2021 Aug 16, 2021	BUY	$32.29 - $39.68 $4.42 Million - $5.43 Million	136,957 Added 913.05%	151,957 $5.72 Million
Q1 2021 May 17, 2021	SELL	$34.75 - $57.5 $868,750 - $1.44 Million	-25,000 Reduced 62.5%	15,000 $538,000
Q4 2020 Feb 12, 2021	SELL	$32.0 - $59.2 $7.16 Million - $13.2 Million	-223,704 Reduced 84.83%	40,000 $1.94 Million
Q3 2020 Nov 13, 2020	BUY	$28.83 - $43.17 $7.6 Million - $11.4 Million	263,704 New	263,704 $9.78 Million

152

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.